drugset / Trial / NCT00588952

Ketamine/Placebo Family History Positive Study

NCT00588952 ↗

RandomizedParallel-groupDouble-blindOther

Summary

The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high-risk individuals that may lead to the transition from moderate to excessive use of alcohol.

Timeline

Start
2001-03
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.23 mg/kg Intravenous

Indications